Evidence map›Paper›PMID 39817121›Full record

ArticleWorld journal of gastrointestinal oncology2025

Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma.

Hui Wan, Yu-Xin Zhang, Guan-Yue Shan, Jun-Ya Cheng, Duan-Rui Qiao, Yi-Ying Liu, Wen-Na Shi, Hai-Jun Li

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui WanInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Yu-Xin ZhangInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Guan-Yue ShanInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Jun-Ya ChengInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Duan-Rui QiaoInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Yi-Ying LiuInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Wen-Na ShiInstitute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China.
Hai-Jun LiInstitute of Liver Diseases, Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130061, Jilin Province, China. hjli2012@jlu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this editorial, we comment on the article by Mu

Indexed as

Antiviral therapyHepatitis B virusHepatitis B virus-DNAHepatocellular carcinomaImmune tolerance

Identifiers

PMID39817121
PMCPMC11664622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.